These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27258433)

  • 1. Intraocular Pharmacokinetics of Intravitreal Aflibercept (Eylea) in a Rabbit Model.
    Park SJ; Choi Y; Na YM; Hong HK; Park JY; Park KH; Chung JY; Woo SJ
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2612-7. PubMed ID: 27258433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pharmacokinetics of intravitreal vascular endothelial growth factor-Trap in a rabbit model.
    Park SJ; Oh J; Kim YK; Park JH; Park JY; Hong HK; Park KH; Lee JE; Kim HM; Chung JY; Woo SJ
    Eye (Lond); 2015 Apr; 29(4):561-8. PubMed ID: 25592118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes.
    Niwa Y; Kakinoki M; Sawada T; Wang X; Ohji M
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6501-5. PubMed ID: 26447985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Fc Region in the Vitreous Half-Life of Anti-VEGF Drugs.
    Joo K; Park SJ; Choi Y; Lee JE; Na YM; Hong HK; Park KH; Kim HM; Chung JY; Woo SJ
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4261-4267. PubMed ID: 28850637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Bioavailability of Complete and Half-Dose Intravitreal Ziv-Aflibercept in an Experimental Model: Contralateral Eye Study.
    Lashay A; Delrish E; Ashrafi E; Movassat M; Asadi-Amoli F; Dinarvand R; Abrishami M
    Ophthalmic Surg Lasers Imaging Retina; 2019 Dec; 50(12):785-790. PubMed ID: 31877224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular pharmacokinetics of ranibizumab in vitrectomized versus nonvitrectomized eyes.
    Ahn SJ; Ahn J; Park S; Kim H; Hwang DJ; Park JH; Park JY; Chung JY; Park KH; Woo SJ
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):567-73. PubMed ID: 24398088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Biodistribution and Intravitreal Pharmacokinetic Properties of Bevacizumab, Ranibizumab, and Aflibercept in a Nonhuman Primate Model.
    Christoforidis JB; Briley K; Binzel K; Bhatia P; Wei L; Kumar K; Knopp MV
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5636-5645. PubMed ID: 29094168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of subconjunctival aflibercept in treating choroidal neovascularization.
    Nirmal J; Barathi VA; Dickescheid A; Wey YS; Nirmal S; Raja MM; Venkatraman S; Agrawal R
    Exp Eye Res; 2020 Oct; 199():108187. PubMed ID: 32795527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravitreal ranibizumab (Lucentis).
    Bakri SJ; Snyder MR; Reid JM; Pulido JS; Ezzat MK; Singh RJ
    Ophthalmology; 2007 Dec; 114(12):2179-82. PubMed ID: 18054637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT.
    Christoforidis JB; Williams MM; Kothandaraman S; Kumar K; Epitropoulos FJ; Knopp MV
    Curr Eye Res; 2012 Dec; 37(12):1171-4. PubMed ID: 22991959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Pharmacokinetic Properties of Intravitreally Injected Aflibercept in Rabbits After Using Brinzolamide/Timolol Eye Drops.
    Zhou T; Li X; Yang J; Xia H; Liu Q; He J; Zhang J
    J Ocul Pharmacol Ther; 2023 Apr; 39(3):229-234. PubMed ID: 36779981
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration.
    Fauser S; Schwabecker V; Muether PS
    Am J Ophthalmol; 2014 Sep; 158(3):532-6. PubMed ID: 24879948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of RC28-E, a fusion protein targeting VEGF and bFGF: Pharmacokinetics and ocular distribution in primates.
    Jiang J; Wang L; Kou X; Liu Z; Huang M; Li H; Wu C
    Exp Eye Res; 2020 Jan; 190():107823. PubMed ID: 31600485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits.
    Gaudreault J; Fei D; Beyer JC; Ryan A; Rangell L; Shiu V; Damico LA
    Retina; 2007; 27(9):1260-6. PubMed ID: 18046235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravitreal bevacizumab (Avastin).
    Bakri SJ; Snyder MR; Reid JM; Pulido JS; Singh RJ
    Ophthalmology; 2007 May; 114(5):855-9. PubMed ID: 17467524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison of ketorolac after intracameral, intravitreal, and suprachoroidal administration in rabbits.
    Wang M; Liu W; Lu Q; Zeng H; Liu S; Yue Y; Cheng H; Liu Y; Xue M
    Retina; 2012; 32(10):2158-64. PubMed ID: 23099451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection site and pharmacokinetics after intravitreal injection of immunoglobulin G.
    Miura Y; Uematsu M; Teshima M; Suzuma K; Kumagami T; Sasaki H; Kitaoka T
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):35-41. PubMed ID: 21182428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular Pharmacokinetics of Aflibercept and Vascular Endothelial Growth Factor-A.
    Celik N; Scheuerle A; Auffarth GU; Kopitz J; Dithmar S
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5574-8. PubMed ID: 26305529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dosage form on the intravitreal pharmacokinetics of diclofenac.
    Durairaj C; Kim SJ; Edelhauser HF; Shah JC; Kompella UB
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4887-97. PubMed ID: 19516015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended Pharmacokinetic Model of the Intravitreal Injections of Macromolecules in Rabbits. Part 2: Parameter Estimation Based on Concentration Dynamics in the Vitreous, Retina, and Aqueous Humor.
    Lamminsalo M; Karvinen T; Subrizi A; Urtti A; Ranta VP
    Pharm Res; 2020 Oct; 37(11):226. PubMed ID: 33094404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.